3136 results for «3073»

Filter By

3136 results

Future-proof your TAVI programme: increased need to enhance pathway efficiencies

21 May 2025 – From EuroPCR 2025

Explore evolving guidelines, demographic changes, and new data shaping lifetime TAVI management. Learn precision strategies to optimise patient outcomes before, during, and after TAVI, including post-procedural care and PCI with the Evolut FX+ valve. Discover practical approaches to boost hospital efficiency and embrace innovative technologies that...

Future-proof your TAVI programme: increased need to enhance pathway efficiencies

How do I confidently expand my drug-coated balloon practice?

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...

How do I confidently expand my drug-coated balloon practice?

PCR's Got Talent Round 1 - Session 1

20 May 2025 – From EuroPCR 2025

Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.

PCR's Got Talent Round 1 - Session 1

How to handle the most clinically relevant challenges in TAVI

21 May 2025 – From EuroPCR 2025

This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...

How to handle the most clinically relevant challenges in TAVI

How to optimise TAVI outcomes in the Asian-Pacific population?

22 May 2025 – From EuroPCR 2025

What are the key considerations for TAVI in Asian-Pacific patients? This EuroPCR 2025 session focuses on optimising outcomes in anatomically and clinically specific contexts, such as patients with small annuli. Learn how the latest intra-annular self-expanding devices can help reduce post-procedural pacemaker implantation (PPI) rates, and...

How to optimise TAVI outcomes in the Asian-Pacific population?

Tailoring transcatheter mitral therapies: a new era

20 May 2025 – From EuroPCR 2025

This session focuses on the evolving landscape of transcatheter mitral valve therapies. Learn about strategic programme development, patient phenotyping to guide device selection and repair versus replacement decisions, and the latest innovations and approvals in transcatheter mitral valve replacement.

Tailoring transcatheter mitral therapies: a new era

If I can’t stent it, should I care? Unmasking hidden atherosclerosis through novel imaging techniques

22 May 2025 – From EuroPCR 2025

Unveil the potential of novel imaging techniques in identifying hidden atherosclerosis and silent inflammation. This session discusses the role of perivascular adipose tissue in plaque development, highlights advances in early inflammation detection, and explores clinical management of patients with athero-inflammation beyond traditional stenting options.

If I can’t stent it, should I care? Unmasking hidden atherosclerosis through novel imaging techniques

Best companion's case on complications for stable coronary artery disease PCI: episode 1

20 May 2025 – From EuroPCR 2025

This session focuses on managing complications during PCI for stable coronary artery disease through real-world case presentations. Topics include severe dissections, unexpected procedural complications, and escalation of routine interventions, providing practical insights for complication navigation.

Best companion's case on complications for stable coronary artery disease PCI: episode 1

TAVI - Procedural complications

20 May 2025 – From EuroPCR 2025

Review procedural complications encountered during TAVI, including rare adverse events, management of balloon rupture, annulus rupture with tamponade, and unexpected intraoperative challenges. Gain insights into innovative rescue techniques and decision-making under critical conditions.

TAVI - Procedural complications

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

20 May 2025 – From EuroPCR 2025

This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

Primary PCI outside of the box: unusual STEMI cases

20 May 2025 – From EuroPCR 2025

This session presents unusual STEMI cases managed with primary PCI outside conventional protocols. Cases include heavily calcified lesions, STEMIs with non-flow-limiting stenoses, simultaneous occlusions with cardiac arrest, and other complex presentations, highlighting diverse interventional strategies.

Primary PCI outside of the box: unusual STEMI cases

Pushing boundaries in complex PCIs: unique DES technology for complex lesions and patients

21 May 2025 – From EuroPCR 2025

Explore cutting-edge strategies in complex PCI through four detailed clinical cases: a challenging left main bifurcation, a complex procedure using Guideliner Extension Catheters (GEC), an acute coronary syndrome intervention, and treatment of a patient with high bleeding and ischemic risks. This session demonstrates how thorough patient...

Pushing boundaries in complex PCIs: unique DES technology for complex lesions and patients

Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies

21 May 2025 – From EuroPCR 2025

Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...

Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies

RevoEdge high pressure cutting balloon in PCI: innovate, cut, and conquer

20 May 2025 – From EuroPCR 2025

Discover how the next-generation RevoEdge high-pressure cutting balloon is transforming PCI with innovative design and proven clinical outcomes. This session presents a multicenter randomised trial and real-world case discussions, showcasing RevoEdge’s effectiveness in tackling resistant, complex lesions—including long, tortuous, and fibrotic cases. Learn practical tips, tricks,...

RevoEdge high pressure cutting balloon in PCI: innovate, cut, and conquer

Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer

22 May 2025 – From EuroPCR 2025

Refractory angina affects more than 100 million people globally and is associated with a significantly increased risk of adverse cardiovascular events. Treating this condition effectively remains a major clinical challenge. This session provides detailed insights into the use of the Shockwave Reducer device as an innovative therapeutic...

Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer

Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights the latest device innovations reshaping interventional cardiology. Learn how the Myval OCTAPRO THV combines predictable deployment with minimal foreshortening for improved outcomes in structural heart procedures. In the coronary space, the session explores the renewed appeal of the “leave nothing behind”...

Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary

Simplify PCI! Know where and how to win with drug-coated balloon

22 May 2025 – From EuroPCR 2025

This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...

Simplify PCI! Know where and how to win with drug-coated balloon

Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...

Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier

Successful finale - Latest best practices and technologies for large hole arterial and venous closure

22 May 2025 – From EuroPCR 2025

This session covers the latest best practices and technologies for large hole arterial and venous closure, focusing on minimising vascular complications.

Learn about a novel patch-based closure system with encouraging early results in TAVI cases, highlighting the importance of deployment angle and ultrasound guidance.

The venous case presentation...

Successful finale - Latest best practices and technologies for large hole arterial and venous closure

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
Didn’t find what you were looking for?